Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Endocrine
Literature
1.
2.
D.H. Nelson, J.W. Meakin, J.B. Dealy Jr, D.D. Matson, K. Emerson Jr, G.W. Thorn, ACTH-producing tumor of the pituitary gland. N. Engl. J. Med. 259, 161–164 (1958)CrossRefPubMed
3.
L.F. Morris, R.S. Harris, D.R. Milton, S.G. Waguespack, M.A. Habra, C. Jimenez, R. Vassilopoulou-Sellin, J.E. Lee, N.D. Perrier, E.G. Grubbs, Impact and timing of bilateral adrenalectomy for refractory adrenocorticotropic hormone-dependent Cushing’s syndrome. Surgery 154, 1174–1184 (2013)CrossRefPubMedPubMedCentral
4.
J.A. Verhelst, P.J. Trainer, T.A. Howlett, L. Perry, L.H. Rees, A.B. Grossman, J.A. Wass, G.M. Besser, Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing’s syndrome. Clin. Endocrinol. (Oxf.). 35, 169–178 (1991)CrossRefPubMed
5.
E. Valassi, I. Crespo, I. Gich, J. Rodríguez, S.M. Webb, A reappraisal of the medical therapy with steroidogenesis inhibitors in Cushing’s syndrome. Clin. Endocrinol. (Oxf.). 77, 735–742 (2012)CrossRefPubMed
6.
F. Ceccato, M. Zilio, M. Barbot, N. Albiger, G. Antonelli, M. Plebani, S. Watutantrige-Fernando, C. Sabbadin, M. Boscaro, C. Scaroni, Metyrapone treatment in Cushing’s syndrome: a real-life study. Endocrine 62, 701–711 (2018)CrossRefPubMed
7.
A.M. Pereira, M.O. van Aken, H. van Dulken, P.J. Schutte, N.R. Biermasz, J.W. Smit, F. Roelfsema, J.A. Romijn, Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing’s disease. J. Clin. Endocrinol. Metab. 88, 5858–5864 (2003)CrossRefPubMed
8.
E. Valassi, B.M. Biller, B. Swearingen, F. Pecori Giraldi, M. Losa, P. Mortini, D. Hayden, F. Cavagnini, A. Klibanski, Delayed remission after transsphenoidal surgery in patients with Cushing’s disease. J. Clin. Endocrinol. Metab. 95, 601–610 (2010)CrossRefPubMedPubMedCentral
Metadata
Title
Enlarged adrenal glands: the long-term consequence of Cushing’s disease
Authors
Yorihiro Iwasaki
Akihiro Hamasaki
Publication date
01-03-2019
Publisher
Springer US
Published in
Endocrine / Issue 3/2019
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-01844-w

Other articles of this Issue 3/2019

Endocrine 3/2019 Go to the issue

Original Article

Impaired HPA axis function in diabetes involves adrenal apoptosis and phagocytosis

Original Article

The effects of sampling lateralization on bilateral inferior petrosal sinus sampling and desmopressin stimulation test for pediatric Cushing's disease

Original Article

Long-term control of Paget’s disease of bone with low-dose, once-weekly, oral bisphosphonate preparations, in a “real world” setting

Original Article

18F-choline PET/CT incidental thyroid uptake in patients studied for prostate cancer

Mini Review

The patterns and treatment of postoperative hemorrhage and hematoma in total endoscopic thyroidectomy via breast approach: experience of 1932 cases

Original Article

In vitro antitumor activity of progesterone in human adrenocortical carcinoma
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits